I Love Organigram Now!!!

I wrote yesterday about Organigram (OGI) at Seeking Alpha, discussing how it could soar in 2025. The stock is up this year despite a lot of pressure on the cannabis market. I think it could go up a lot more. Here is the chart:

This is not the first time I have written about Organigram here. My first piece on cannabis stocks was the first day of 2024, an article where I expressed some caution for the sector. I didn't mention how much I liked Organigram then, but I did include it as a member of my 26-stock Focus List at the time. I did say this about Canadian LPs:

For those looking at investing in the cannabis market, I think this is a big bet that has to be made right now on cannabis operators that could go well or go poorly. I have found attractively priced Canadian operators and ancillary companies that look better.

At the time, it was 19% of my model portfolio at 420 Investor. It is now as well, but there have been some big changes throughout the year.

I had written very positively in late 2023 at Seeking Alpha as an entry in its value stock article contest. It was $1.15 when I called it a great value stock.

Of course, the stock did extremely well afterwards, peaking near $3 in March. In late February, I wrote my second cannabis related article here, explaining why I no longer liked it. The stock was then $2.02. Wow did I feel silly writing that article when the stock soared in March! Well, it's better to be lucky than smart, and I got very lucky. In late March, the company surprised me and the rest of the market with a capital raise, and the stock sank. I was lucky and had none! In late April, two months after I warned here about OGI, I shared that I liked it again. The stock was then $1.86.

I continue to focus my cannabis efforts at Seeking Alpha, through my articles there or my free blogs, and through my 420 Investor service that I run there. I have been involved with Seeking Alpha since 2007 and really like the organization. One thing that it seems to have done is to restrict the access to articles. I am not complaining about this, and I would suggest to anyone that buying a subscription to their "Premium" is worth it, but I have started to post more blogs. On November 10th, I wrote about Organigram and another LP that I like, explaining why they are my favorite Canadian licensed producers of cannabis. They still are, though their prices are a bit lower now.

I continue to believe that the biggest gains could come from MSOs if rescheduling takes place and wipes out the evil 280E taxation that plagues the American cannabis companies, but it will be quite nasty if that doesn't happen. The good news is that the DEA is moving forward with that process.

I don't like all Canadian LPs, but I really like Organigram. It has limited downside and could go up a lot. That is a fantastic combination for stocks.